Death Clinical Trial
Official title:
Prospective Multicenter Study to Evaluate the Validity of the Specified Apgar-score in Asphyxiated Infants Under Resuscitation
The specified Apgar-Score in combination with the AAP-Score predicts the morbidity and mortality of asphyxiated newborns.
In the first place the Apgar-score helps to evaluate the postnatal adaptation of the newborn
and is used as an index for resuscitative interventions. However, it has been shown in the
past that the score has its limits and may be influenced by several factors such as the
variability of the examiner, drugs, parental age, neurological impairment of the child as
well as premature delivery. Previous studies have proven, however, that the evaluation of
the infant's condition with the conventional Apgar-score is affected due to non-uniform
definitions.
For this, an explanation might be that on the one hand the inaccuracy of the score is based
on missing guidelines for the assessment of the score in premature infants. Both, muscle
tone and reflexes of extremely premature infants are physiologically more immature than they
are in term newborns. In conclusion, healthy premature infants often achieve a lower
Apgar-score than their term counterparts. However, this is rather an expression of their
immaturity than a sign for postnatal depression.
Another reason for the inaccuracy of the score might have its origin in the limited
comparability and validity of the Apgar-score when applied in resuscitated newborns. Until
now there is no consensus how to assess the condition of the newborn under resuscitation,
since the individual characteristics composing the score are affected by the resuscitation
itself. For example, heart frequency and skin colour are improved by sufficient ventilation.
So far there are no regulations on how this fact should be considered while assessing the
score. A description of the infant's condition without interventions respectively with
interruption of the interventions applied would be in contrast to Apgar's intention to have
a score "which could be determined easily without interfering with the care of the infant".
The description of the condition independently of the interventions applied offers a
practicable alternative. By using this method the resuscitation will not be interrupted and
the score will not express the efforts of the infant but describe its condition,
independently of the requirements needed to achieve this condition.
To validate the accuracy of the specified version of the Apgar-score to predict neonatal
mortality and long term outcome in preterm infants, the multicenter TEST-Apgar study has
been performed recently.
The American Academy of Pediatrics (AAP) is also aware of the problem concerning the
description of resuscitated newborns. As a solution, it was suggested to use an expanded
Apgar-score reporting form that accounts for concurrent resuscitative interventions
(AAP-Score). This way the infant's condition can be estimated and documented more easily.
Although the AAP-Score has been suggested 4 years ago, data on the predictive reliability
are not available yet. This aspect regarding the neonatal mortality of premature infants has
also been analyzed in the TEST-Apgar study. The results show that the specified Apgar-Score
should be used in combination with the AAP-Score in the future to appraise the condition of
premature infants. Its predictive value regarding the neonatal mortality of premature
infants is very good. Detailed results will be published soon.
The present study analyzes the validity of the specified Apgar- and the AAP- Scores in
asphyxiated infants >37 weeks of gestation undergoing resuscitation. Since the Apgar-score
presents an index for the postnatal adaption to the extra-uterine life, reflects the
efficiency of resuscitative interventions and also serves as an inclusion criteria for
specific types of therapy (e.g. hypothermia therapy), it is necessary, to standardise the
use of the Apgar-score and improve its prognostic value.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Recruiting |
NCT02552706 -
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
|
N/A | |
Completed |
NCT01569178 -
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
|
Phase 3 | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A | |
Completed |
NCT00399503 -
Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack
|
N/A | |
Completed |
NCT05128799 -
Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions
|
||
Completed |
NCT00340015 -
A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons
|
||
Active, not recruiting |
NCT01618123 -
Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit
|
||
Completed |
NCT01008241 -
South Florida Residents Knowledge and Opinions on End-of-Life Issues
|
||
Completed |
NCT00225394 -
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
|
Phase 4 | |
Terminated |
NCT05518474 -
Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness
|
N/A | |
Completed |
NCT02533128 -
Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
|
N/A | |
Recruiting |
NCT05199025 -
Biomarkers in Perioperative Management
|
||
Not yet recruiting |
NCT06371677 -
Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units
|
||
Completed |
NCT04709120 -
Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
|
||
Enrolling by invitation |
NCT05374291 -
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
|
Phase 3 | |
Recruiting |
NCT01792739 -
Lactobacillus Preparation on the Incidence of Diarrhea
|
Phase 4 | |
Completed |
NCT00753428 -
Community-based Evaluation of a Pilot PMTCT Project in Kafue District
|
||
Completed |
NCT00495690 -
Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
|
Phase 3 | |
Completed |
NCT00912600 -
Intensive Care Unit (ICU) Admission Decisions in the Elderly : the ICE-CUB Study
|
N/A |